CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Viking Therapeutics slips on planned stock, convertible offerings

By Reuters News21:01 (UTC), 23 September 2026 Updated

** Shares of Viking Therapeutics VKTX.O down 8% at $38.32 post-market as co looks to raise capital

** VKTX announces public offerings of $200 mln in stock and $200 mln convertible bonds due Oct 15, 2032

** VKTX shares surged ~36% to $40.85 on Tues after co's obesity drug, VK2735, showed durable weight-loss benefit in patients in a study compared with those on placebo

** Co intends to use net proceeds from the offerings for clinical development, advancement and commercialization of its VK2735 program, and advancement of its VK3019 program, among other purposes

** Morgan Stanley and JP Morgan joint bookrunners for both offerings

** VKTX shares added another 2% to close at $41.65 on Weds

** San Diego, California-based firm has approx $4.9 bln market cap, based on ~116.65 mln shares outstanding

** Avg rating of 20 analysts is "buy"; median PT $100, per LSEG

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.